Viewing nowClopact Tablet (Clopidogrel Sulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Ahn-Guk Pharmaceutical Co., Ltd.

MFDS item code 200604227 · Notified 2006.05.04 · Insurance code 650202070
Improvement of atherosclerotic symptoms, improvement of acute coronary syndrome, and prevention of thromboembolism in atrial fibrillation
This medication is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, and peripheral arterial disease. It also effectively improves atherosclerotic symptoms such as death due to cardiovascular complications, myocardial infarction, and stroke in patients with acute coronary syndrome, i.e., those who have unstable angina or non-Q wave myocardial infarction, and have undergone coronary interventions or coronary artery bypass surgery. Additionally, it helps reduce the risk of stroke and thromboembolism in patients with atrial fibrillation who have one or more vascular risk factors and are unable to use vitamin K antagonists. Therefore, it is widely used for the prevention and symptom improvement of cardiovascular diseases in these patients.
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel orally at a dose of 75 mg once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg once daily, followed by an oral maintenance dose of 75 mg once daily. Aspirin 75 ~ 325 mg should be coadministered with this drug once daily. 3. For patients with atrial fibrillation, administer this drug orally at a dose of 75 mg once daily. Aspirin 75 ~ 100 mg should be coadministered with this drug once daily. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This drug may be taken without regard to food.
This medication is used to prevent blood clots by helping the blood flow more easily, thereby helping to prevent heart attacks and strokes. Individuals with a genetic impairment of a specific enzyme (CYP2C19) may exhibit reduced efficacy of this medication, and in such cases, alternative treatment options should be considered. It is advisable not to co-administer this drug with certain medications (CYP2C19 inducers), as the concentration of the drug in the body may increase and the risk of bleeding may be elevated. Due to an increased risk of bleeding, individuals with a history of bleeding, severe liver impairment, those who are breastfeeding, or have certain genetic disorders should avoid using this medication. Patients with a high risk of bleeding, those about to undergo surgery, or patients on other bleeding risk medications should use this medication cautiously, and the medication should be discontinued for a certain period before surgery. This medication may cause side effects such as bleeding, reduced blood cell count, gastrointestinal symptoms (abdominal pain, diarrhea, etc.), and skin rashes; immediate consultation with a physician is warranted if any abnormal symptoms occur. If bleeding symptoms appear, inform medical personnel immediately, and it may be necessary to monitor the condition through blood tests. During pregnancy, the risk to the fetus is minimal, but there is a risk of bleeding at the time of delivery; thus, discontinuation of the medication prior to childbirth is recommended. In the case of breastfeeding, consider stopping the breastfeeding or discontinuing the medication, as it may be excreted in breast milk. Use in children is not recommended as the safety and efficacy have not been established. Elderly patients may have reduced physiological functions, increasing the risk of side effects like bleeding, thus dose adjustment and careful monitoring are necessary. Due to significant drug interactions, always inform healthcare providers about the use of this medication before starting new drugs or prior to surgery. Overdose may increase the risk of bleeding, and as there is no specific antidote, treatment such as platelet transfusions may be necessary in case of severe bleeding. Store this medication out of reach of children, and do not transfer it to other containers.
Not everyone experiences these, and they can vary from person to person.
The medication should be stored in a tightly sealed container to protect it from exposure to air and moisture. It is crucial to maintain a storage temperature between 1°C and 30°C at room temperature. Proper storage will help maintain the medication's effectiveness and ensure safe usage.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Ahn-Guk Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.